Average Co-Inventor Count = 1.76
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cellerant Therapeutics, Inc. (10 from 17 patents)
2. Abbvie Stemcentrx LLC (1 from 40 patents)
11 patents:
1. 10723805 - Antibodies specific for CLL-1
2. 10428156 - Anti-MFI2 antibodies and methods of use
3. 10301394 - Antibodies that specifically bind to TIM3
4. 9850314 - Antibodies specific for CLL-1
5. 9631026 - Antibodies that specifically bind to TIM3
6. 9371390 - Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof
7. 9163090 - Antibodies specific for CLL-1
8. 8841418 - Antibodies that specifically bind to TIM3
9. 8715619 - Compositions and methods for treating haematological proliferative disorders of myeloid origin
10. 8709715 - Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof
11. 8383095 - Methods and compositions for enhancing engraftment of hematopoietic stem cells